Introduction
Introduction

Endothelial cells (EC) play an essential regulatory role in the capacity of the vasculature to adequately respond to injury or hypoxia. In arteriogenesis, EC react to elevated shear stress by recruiting and activating leucocytes that mediate remodelling of small collateral arterioles. In tissue ischemia, novel capillaries are generated by proliferation and migration of EC that sprout from pre-existing capillaries. The molecular mechanisms underlying this directive role of EC in vascular plasticity have been extensively studied and involve numerous environmental cues that elicit complex, but tightly coordinated responses in the expression of genes controlling proliferation, migration and cell-differentiation
.
MicroRNAs constitute a recently recognized class of short, non-coding RNA molecules (~21 nt) that could potentially regulate the activity of 30% of all genes at the post-transcriptional level [2] . The ability of microRNAs to regulate multiple targets provides a means for coordinated control of gene expression, while also making them especially attractive candidates for regulating both cell-type specific differentiation and modulation of cell function [3] .
Recently, evidence supporting a role for endothelial microRNAs in the control of neovascularization has been provided [4] , with in vitro studies demonstrating both pro-angiogenic microRNAs (let 7b, [5] miR-27b, [5] miR-130a, [6] miR-210 [7] ) as well as microRNAs with anti-angiogenic actions (miR-221/222) [8, 9] . To study the role of endothelial microRNAs in neovascularization, we recently generated an inventory of known and novel microRNAs [11] . Because EGFL7 expression is augmented in adult angiogenesis and vascular injury, [12] we suggested that coexpression of miR-126 may also play a role in neovascularization. Recently, two papers have described a role for miR-126 in vascular development in mice [13] and zebrafish [14] . [18] . To localize the endothelium in these sections, we co-stained for the endothelial marker CD31 (Fig. 1B) 
Antagomir silencing of MiR-126 in EC
Antagomirs have been used to specifically silence microRNAs [15] (Fig. 3C and D) . (Fig. 4A and B 
Antagomir silencing of MiR-126 does not affect arteriogenesis
). Whereas the mice treated with antagomir-126 (LD) show only a marginal reduction in miR-126 expression (1.9 fold, P Ͻ 0.05 versus scramblemir [LD]), mice treated with antagomir-126 (HD) displayed an over 1000 fold reduction in miR-126 expression compared to the scramblemirtreated mice (P Ͻ 0.001). In contrast, no significant differences were observed for the miR-423 levels in all groups. Our data demonstrate that in vivo silencing of the endothelial miR-126 remains readily detectable ten days after administration of a single dose of 1.0 mg of antagomir-126. Moreover, we conclude that miR-126 is not directly involved in arteriogenesis.
Antagomir silencing of MiR-126 impairs ischemia-induced angiogenesis
To assess the effect of miR-126 silencing on the ischemia-induced angiogenic response, we performed a detailed quantitative analysis of CD31 stained capillaries in sections of gastrocnemius muscle of all treated mice (Fig. 4D and E). Mice treated with a single dose antagomir-126 (HD) showed a markedly lower density of capillary vessels compared to antagomir-126 (LD) or both control groups (35% versus 118% (n ϭ 6, P Ͻ 0.05), 109% (n ϭ 6, P Ͻ 0.001) and 100% (n ϭ 6, P Ͻ 0.01)). These studies demonstrate that silencing of miR-126 impairs the angiogenic response to ischemia.
Antagomir silencing of MiR-126 impairs EC outgrowth in aortic explant cultures
Discussion
Previously, miR-126 was found to be expressed in the heart and blood vessels of zebrafish embryos [18] . We [20, 21] and (2) chemically modified and cholesterol-conjugated RNAs termed antagomirs for the rapid and specific degradation of microRNAs in multiple tissues after tail vein injection [15] . As cholesterol uptake is a salient feature shared by virtually all cells, including EC, we designed an antagomir directed to miR-126. [13, 14] . Here 
001). (C) Quantitative evaluation of blood flow recovery measured before and after induction of ischemia by laser Doppler perfusion imaging and expressed as a ratio of the left (ischemic) and right (non-ischemic) limb. (D) Representative microscopic images of CD31 staining in ischemic murine gastrocnemius muscles. (E) Quantification of the total area of capillaries in sections of the gastrocnemius muscle 10 days after induction of ischemia
